(2)
Beneficial ownership as of January 8, 2025 as reported by D. E. Shaw & Co., L.P., D. E. Shaw & Co., L.L.C., and David E. Shaw on a Schedule 13G filed with the SEC on January 15, 2025, pursuant to which D. E. Shaw & Co., L.P. has shared voting power and shared dispositive power with respect to 2,501,830 shares; D. E. Shaw & Co., L.L.C. has shared voting power and shared dispositive power with respect to 2,470,480 shares; and David E. Shaw has shared voting power and shared dispositive power with respect to 2,501,830 shares. D. E. Shaw & Co., L.P. may be deemed to beneficially own 2,501,830 shares, composed of (i) 1,421,445 shares in the name of D. E. Shaw Valence Portfolios, L.L.C., (ii) 224,800 shares that D. E. Shaw Valence Portfolios, L.L.C. has the right to acquire through the exercise of call options, (iii) 761,835 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., (iv) 62,300 shares in the name of D. E. Shaw Composite Portfolios, L.L.C., and (v) 31,450 shares under the management of D. E. Shaw Investment Management, L.L.C. D. E. Shaw & Co., L.L.C. may be deemed to beneficially own 2,470,480 shares, composed of (i) 1,421,445 shares in the name of D. E. Shaw Valence Portfolios, L.L.C., (ii) 224,800 shares that D. E. Shaw Valence Portfolios, L.L.C. has the right to acquire through the exercise of call options, (iii) 761,835 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., (iv) 62,300 shares in the name of D. E. Shaw Composite Portfolios, L.L.C., and (v) 100 shares in the name of D. E. Shaw Investment Management Special Investment Fund, L.L.C. David E. Shaw may be deemed to beneficially own 2,501,830 shares, composed of (i) 1,421,445 shares in the name of D. E. Shaw Valence Portfolios, L.L.C., (ii) 224,800 shares that D. E. Shaw Valence Portfolios, L.L.C. has the right to acquire through the exercise of call options, (iii) 761,835 shares in the name of D. E. Shaw Oculus Portfolios, L.L.C., (iv) 62,300 shares in the name of D. E. Shaw Composite Portfolios, L.L.C., and (v) 31,450 shares under the management of D. E. Shaw Investment Management, L.L.C. David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as the President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P., which in turn is the investment adviser of D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw Oculus Portfolios, L.L.C., and D. E. Shaw Composite Portfolios, L.L.C. and the managing member of D. E. Shaw Investment Management, L.L.C., which in turn is the investment adviser of D. E. Shaw Investment Management Special Investment Fund, L.L.C., and by virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member of D. E. Shaw & Co., L.L.C., which in turn is the manager of D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw Oculus Portfolios, L.L.C., D. E. Shaw Composite Portfolios, L.L.C., and D. E. Shaw Investment Management Special Investment Fund, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, the 2,501,830 shares as described above, and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares. David E. Shaw disclaims beneficial ownership of such shares. The principal address for each reporting person is Two Manhattan West, 375 Ninth Avenue, 52nd Floor, New York, NY, 10001.
(3)
Includes an aggregate of (i) 966,059 shares of common stock and (ii) 50,018 RSUs which vest within 60 days of February 24, 2025. Dr. Lin is our President, Chief Executive Officer and Chairman of the Board.
(4)
Includes an aggregate of (i) 228,374 shares of common stock and (ii) 4,120 RSUs which vest within 60 days of February 24, 2025. Mr. Lin is a member of our Board.
(5)
Includes an aggregate of (i) 215,296 shares of common stock and (ii) 4,120 RSUs which vest within 60 days of February 24, 2025. Mr. Yeh is a member of our Board.
(6)
Includes an aggregate of (i) 149,571 shares of common stock and (ii) 4,120 RSUs which vest within 60 days of February 24, 2025. Mr. Black is a member of our Board.
(7)
Includes an aggregate of (i) 116,699 shares of common stock; (ii) 4,120 RSUs which vest within 60 days of February 24, 2025; and (iii) 2,380 shares of common stock held of record by Norman Kinsella. Mr. Kinsella is Ms. DeLaney’s spouse. Ms. DeLaney is a member of our Board.
(8)
Includes an aggregate of (i) 156,812 shares of common stock; (ii) 4,120 RSUs which vest within 60 days of February 24, 2025; and (iii) 15,000 shares of common stock held of record by Yuh-Mei Chung. Ms. Chung is Dr. Chen’s spouse. Dr. Chen is a member of our Board.
(9)
Includes an aggregate of (i) 106,468 shares of common stock and (ii) 4,120 RSUs which vest within 60 days of February 24, 2025. Dr. Loboa is a member of our Board.
(10)
Includes an aggregate of (i) 90,458 shares of common stock and (ii) 15,603 RSUs which vest within 60 days of February 24, 2025. Dr. Chang is our Senior Vice President and North America General Manager.
(11)
Includes an aggregate of (i) 89,913 shares of common stock and (ii) 17,210 RSUs which vest within 60 days of February 24, 2025. Dr. Murry is our Chief Financial Officer and Chief Strategy Officer.
(12)
Includes an aggregate of (i) 169,424 shares of common stock and (ii) 14,429 RSUs which vest within 60 days of February 24, 2025. Mr. Yeh is our Senior Vice President and Asia General Manager.
(13)
Includes an aggregate of (i) 24,787 shares of common stock; and (ii) 10,497 RSUs which vest within 60 days of February 24, 2025. Mr. Kuo is our Senior Vice President, Chief Legal and Compliance Officer and Corporate Secretary.
(14)
Includes an aggregate of (i) 2,313,861 shares of common stock; (ii) 132,477 RSUs that vest within 60 days of February 24, 2025; and (iii) 17,380 shares of common stock held by beneficial ownership.